Zeteo Tech

Zeteo Tech

Overview

About Zeteo Tech

Simplify's Rating
Why Zeteo Tech is rated
C+
Rated B on Competitive Edge
Rated C on Growth Potential
Rated C on Differentiation

Industries

Company Size

1-10

Company Stage

Grant

Total Funding

$7.6M

Headquarters

Sykesville, Maryland

Founded

2013

Simplify Jobs

Simplify's Take

What believers are saying

  • CARB-X funded exhaled-breath LRTI studies in September 2025, extending noninvasive diagnostics work.
  • DHS Phase III funding reaches $5.86 million, sustaining defense R&D through January 2027.
  • ADLM 2026 awarded Zeteo’s VAP abstract, increasing credibility with ICU and lab buyers.

What critics are saying

  • CARB-X’s $1 million support still leaves FDA validation and reimbursement unresolved in 2026.
  • Hospitals already use PCR and culture; slow adoption kills a breath-based ICU workflow.
  • If ADLM 2026 data disappoints, Zeteo’s breath-diagnostic commercialization story collapses.

What makes Zeteo Tech unique

  • BreathBiomics captures breath biomolecules for ICU infection diagnosis, unlike pathogen PCR panels.
  • Zeteo’s fieldable mass spectrometers target biosurveillance and clinical diagnostics on one platform.
  • DHS funded DigitalMALDI, proving dual-use national-security and medical-device relevance.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$7.6M

Above

Industry Average

Funded Over

5 Rounds

Grant funding comparison data is currently unavailable. We're working to provide this information soon!
Grant Funding Comparison
Coming Soon

Benefits

Health Insurance

Dental Insurance

401(k) Company Match

Company Equity

Paid Vacation

Paid Sick Leave

Paid Holidays

Company News

Applied Microbiology International
Sep 3rd, 2025
CARB-X to support lower respiratory tract infection diagnostic by ...

CARB-X has awarded Zeteo Tech, Inc. US$1M to execute a workplan for its noninvasive diagnostic platform that aims to evaluate whether exhaled breath can diagnose lower respiratory tract infections (LRTIs) in high-risk populations within critical care environments.

Defense and Munitions
Jan 7th, 2024
Zeteo Tech awarded $1.87M DHS Science & Technology directorate contract

Zeteo Tech, Inc., the biodefense and medical device company and developer of class of fieldable biological mass spectrometers, was awarded a Phase III Small Business Innovation Research contract for $1.87M with a potential value of up to $5.86 million (including options) from the U.S. Department of Homeland Security (DHS).

The Business Journals
Sep 1st, 2021
NSF International Inc. invests into Zeteotech

Zeteo Tech has received a grant from the National Science Foundation to help fund its Covid-fighting tech.

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for Zeteo Tech right now.

Find jobs on Simplify and start your career today

We update Zeteo Tech's jobs every few hours, so check again soon! Browse all jobs →